Björnsson et al., 1994 - Google Patents
Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish populationBjörnsson et al., 1994
- Document ID
- 8280331189102756561
- Author
- Björnsson E
- Janson C
- Håkansson L
- Enander I
- Venge P
- Boman G
- Publication year
- Publication venue
- Allergy
External Links
Snippet
How are the serum concentration of eosinophil cationic protein (S‐ECP) and the blood eosinophil count (B‐Eos) related to symptoms of asthma, allergy, and bronchial hyperresponsiveness (BHR)? We measured S‐ECP, B‐Eos, and total and specific IgE in …
- 102000002802 Eosinophil Cationic Protein 0 title abstract description 109
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/083—Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Björnsson et al. | Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population | |
Tollerud et al. | Asthma, hay fever, and phlegm production associated with distinct patterns of allergy skin test reactivity, eosinophilia, and serum IgE levels. The Normative Aging Study | |
Covar et al. | Safety and application of induced sputum analysis in childhood asthma | |
Janson et al. | Determinants of cough in young adults participating in the European Community Respiratory Health Survey | |
Fitzpatrick et al. | Features of severe asthma in school-age children: atopy and increased exhaled nitric oxide | |
Romagnoli et al. | Near‐fatal asthma phenotype in the ENFUMOSA Cohort | |
Koocher et al. | Psychological adjustment among pediatric cancer survivors | |
Lúdvíksdóttir et al. | Habitual coughing and its associations with asthma, anxiety, and gastroesophageal reflux | |
Renwick et al. | Prevalence and treatment of chronic airways obstruction in adults over the age of 45. | |
Santanello et al. | Measurement characteristics of two asthma symptom diary scales for use in clinical trials | |
Quirce et al. | 5 prevalence of uncontrolled severe persistent asthma in pneumology and allergy hospital units in Spain | |
Shaaban et al. | Allergic rhinitis and onset of bronchial hyperresponsiveness: a population-based study | |
Kreiner et al. | Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial | |
Walsh et al. | Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils | |
Eggleston et al. | Airway hyperreactivity in cystic fibrosis: clinical correlates and possible effects on the course of the disease | |
Novelli et al. | Asthma control in severe asthmatics under treatment with omalizumab: a cross-sectional observational study in Italy | |
Szentkiralyi et al. | Incidence of restless legs syndrome in two population-based cohort studies in Germany | |
Malinovschi et al. | The value of exhaled nitric oxide to identify asthma in smoking patients with asthma-like symptoms | |
Rabinovitch et al. | Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma | |
Shibata et al. | Increased leukotriene E4 in the exhaled breath condensate of children with mild asthma | |
Choi et al. | Bronchial hyperresponsiveness in young children with allergic rhinitis and its risk factors | |
Konradsen et al. | Problematic severe asthma: a proposed approach to identifying children who are severely resistant to therapy | |
Jeppegaard et al. | Validation of ATS clinical practice guideline cut-points for FeNO in asthma | |
Lehmann et al. | Factors determining performance of bronchodilator reversibility tests in middle-aged and elderly | |
Eriksson et al. | Amphetamine abuse during pregnancy: environmental factors and outcome after 14-15 years |